News in the spotlight

New▾
  • Categories
  • New
  • Press articles
  • Press release
  • Publications EN
New
Sectors▾
  • Sectors
  • Advice / Audit / Engineering
  • Deeptech
  • Healthcare / Well-being
  • Industry
  • Personal care services
  • Software providers
Tags▾
  • Tags
  • #buildup
  • #développement
  • #logiciel
  • #santé
  • #santépublique
  • un autre
Dates▾
  • Dates
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
New

15 articles

AstraZeneca Closes Acquisition of Amolyt Pharma

16/07/2024

New

AstraZeneca Closes Acquisition of Amolyt Pharma

Groupe Vigier organizes its transfer with the support of Nov Relance Impact, managed by Turenne Groupe

15/02/2024

New

Groupe Vigier organizes its transfer with the support of Nov Relance Impact, managed by Turenne Groupe

Turenne Groupe is proud to support the EPSA Group in financing its external growth.

15/02/2024

New

Turenne Groupe is proud to support the EPSA Group in financing its external growth.

Société Générale Capital Partenaires (SGCP), Ouest Croissance, Bpifrance and Turenne Groupe renew their confidence in Demgy Group, european leader in high value-added plastics processing

08/12/2023

New

Société Générale Capital Partenaires (SGCP), Ouest Croissance, Bpifrance and Turenne Groupe renew their confidence in Demgy Group, european leader in high value-added plastics processing

PhysioAssist announces successful acquisition by Inogen Inc. to accelerate Simeox’ US market reach and beter serve a larger population of obstructive respiratory patients.

20/10/2023

New

PhysioAssist announces successful acquisition by Inogen Inc. to accelerate Simeox’ US market reach and beter serve a larger population of obstructive respiratory patients.

GERMITEC pursues its ambitious business expansion with a financing round of €11 million from leading French investors in the health sector

10/05/2022

New

GERMITEC pursues its ambitious business expansion with a financing round of €11 million from leading French investors in the health sector

StromaCare has raised €1,500,000 for the development of a new oncology therapy based on the immuno-modulation of the tumor stroma using a monoclonal antibody.

10/05/2022

New

StromaCare has raised €1,500,000 for the development of a new oncology therapy based on the immuno-modulation of the tumor stroma using a monoclonal antibody.

Turenne Santé, supported by BNP Paribas Développement, becomes a minority shareholder in the capital of H.A.C.Pharma to support the company in its growth and strengthen the product portfolio

31/01/2022

New

Turenne Santé, supported by BNP Paribas Développement, becomes a minority shareholder in the capital of H.A.C.Pharma to support the company in its growth and strengthen the product portfolio

Innovacom acquires a stake in Primo1D, world leader in smart electronic thread

25/11/2021

New

Innovacom acquires a stake in Primo1D, world leader in smart electronic thread

Chargement...